Production (Stage)
Kits Eyecare Ltd.
KITS.TO
TSX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 1.37% | 4.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.37% | 4.33% | |||
| Cost of Revenue | 0.67% | -0.89% | |||
| Gross Profit | 2.60% | 14.95% | |||
| SG&A Expenses | 0.42% | 6.56% | |||
| Depreciation & Amortization | -7.00% | 13.84% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.55% | 1.50% | |||
| Operating Income | 17.95% | 138.09% | |||
| Income Before Tax | -39.49% | 1,315.40% | |||
| Income Tax Expenses | -30.37% | 674.92% | |||
| Earnings from Continuing Operations | -42.79% | 1,916.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -42.79% | 1,916.94% | |||
| EBIT | 17.95% | 138.09% | |||
| EBITDA | 11.11% | 70.53% | |||
| EPS Basic | -43.20% | 1,893.55% | |||
| Normalized Basic EPS | -40.11% | 1,321.62% | |||
| EPS Diluted | -38.84% | 1,862.07% | |||
| Normalized Diluted EPS | -39.39% | 1,300.00% | |||
| Average Basic Shares Outstanding | 0.87% | 0.06% | |||
| Average Diluted Shares Outstanding | -0.09% | -0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||